CVS struggled financially last year after underpricing some Aetna insurance plans and the government lowered quality ratings.

The article " 3 Beaten Down Healthcare Stocks Recovering in 2025 " first appeared on MarketBeat.

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Operating income fell for all but two insurance divisions operated by major payers in the fourth quarter. And 2025 may be no ...

Aetna and the University of Texas Medical Branch have reached an agreement to bring customers of the CVS-owned health ...

Digital health is in dire need of consolidation. But startups looking to sell may have to settle for lower prices from their ...

A CVS spokesperson said the Emory collaboration is the first time MinuteClinic has expanded into primary care services in ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

Before serving as interim president at Caremark, DeVaney led sales and account management as president of employer and health ...

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound follows a tough 2024, when its shares dropped over 40% due to missed earnings ...

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment ...